These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 38751015)
1. M6A-mediated hsa_circ_0061179 inhibits DNA damage in ovarian cancer cells via miR-143-3p/TIMELESS. Zhang Y; Wu Y; Shi X; Ding H; Zhou Y; Chen H; Shen F; Chen Y; Zhou J; Zhou D; Wang J Mol Carcinog; 2024 Aug; 63(8):1542-1558. PubMed ID: 38751015 [TBL] [Abstract][Full Text] [Related]
2. Hsa_circ_0001535 inhibits the proliferation and migration of ovarian cancer by sponging miR-593-3p, upregulating PTEN expression. Han Y; Zheng Y; You J; Han Y; Lu X; Wang X; Shi C; Zhu W Clin Transl Oncol; 2023 Oct; 25(10):2901-2910. PubMed ID: 37000289 [TBL] [Abstract][Full Text] [Related]
3. Circular RNA hsa_circ_0007444 inhibits ovarian cancer progression through miR-23a-3p/DICER1 axis. Zhang M; Sun Y; Xu H; Shi Y; Shen R; Teng F; Xu J; Jia X Acta Biochim Biophys Sin (Shanghai); 2023 Apr; 55(4):574-586. PubMed ID: 37057923 [TBL] [Abstract][Full Text] [Related]
4. Circular RNA circ-BNC2 (hsa_circ_0008732) inhibits the progression of ovarian cancer through microRNA-223-3p/ FBXW7 axis. Liu T; Yuan L; Zou X J Ovarian Res; 2022 Aug; 15(1):95. PubMed ID: 35965327 [TBL] [Abstract][Full Text] [Related]
5. Hsa_circ_0013561 promotes epithelial-mesenchymal transition and tumor progression by regulating ANXA2 via miR-23b-3p in ovarian cancer. Lv J; Zhang Y; Yang M; Qiao L; Wang H; Jiang H; Fu M; Qin J; Xu S Cancer Gene Ther; 2024 Jan; 31(1):108-118. PubMed ID: 38102461 [TBL] [Abstract][Full Text] [Related]
6. Blocking hsa_circ_0006168 suppresses cell proliferation and motility of human glioblastoma cells by regulating hsa_circ_0006168/miR-628-5p/IGF1R ceRNA axis. Wang T; Mao P; Feng Y; Cui B; Zhang B; Chen C; Xu M; Gao K Cell Cycle; 2021 Jun; 20(12):1181-1194. PubMed ID: 34024251 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of hsa_circ_0007874 suppresses the progression of ovarian cancer by regulating the miR-760/SOCS3 pathway. Li L; Yu P; Zhang P; Wu H; Chen Q; Li S; Wang Y Cancer Med; 2020 Apr; 9(7):2491-2499. PubMed ID: 32023009 [TBL] [Abstract][Full Text] [Related]
8. Hsa_circ_0031288/hsa-miR-139-3p/Bcl-6 regulatory feedback circuit influences the invasion and migration of cervical cancer HeLa cells. Xu YJ; Yu H; Liu GX J Cell Biochem; 2020 Oct; 121(10):4251-4260. PubMed ID: 32277518 [TBL] [Abstract][Full Text] [Related]
9. Hsa_circ_0001741 Suppresses Ovarian Cancer Cell Proliferations Through Adsorption of miR-188-5p and Promotion of FOXN2 Expression. Wang H; Liang C; Lin J; Dong Y; Wang Y; Xia L Mol Biotechnol; 2024 Jun; 66(6):1477-1483. PubMed ID: 37318741 [TBL] [Abstract][Full Text] [Related]
10. Circ_0078607 inhibits the progression of ovarian cancer via regulating the miR-32-5p/SIK1 network. Jin Y; Wang H J Ovarian Res; 2022 Jan; 15(1):3. PubMed ID: 34983607 [TBL] [Abstract][Full Text] [Related]
11. circ_0025033 promotes ovarian cancer development via regulating the hsa_miR-370-3p/SLC1A5 axis. Ma H; Qu S; Zhai Y; Yang X Cell Mol Biol Lett; 2022 Oct; 27(1):94. PubMed ID: 36273140 [TBL] [Abstract][Full Text] [Related]
12. Circ_0023028 contributes to the progression of laryngeal squamous cell carcinoma by upregulating LASP1 through miR-486-3p. Zheng Y; Duan L; Yang Y; Luo D; Yan B Mol Cell Biochem; 2021 Aug; 476(8):2951-2961. PubMed ID: 33755879 [TBL] [Abstract][Full Text] [Related]
13. Hsa_circ_0004712 downregulation attenuates ovarian cancer malignant development by targeting the miR-331-3p/FZD4 pathway. Zhou X; Jiang J; Guo S J Ovarian Res; 2021 Sep; 14(1):118. PubMed ID: 34507595 [TBL] [Abstract][Full Text] [Related]
14. Circular RNA hsa_circ_0043278 inhibits breast cancer progression via the miR-455-3p/EI24 signalling pathway. Shi Y; Liu C BMC Cancer; 2021 Nov; 21(1):1249. PubMed ID: 34800978 [TBL] [Abstract][Full Text] [Related]
15. Silencing of hsa_circ_0009035 Suppresses Cervical Cancer Progression and Enhances Radiosensitivity through MicroRNA 889-3p-Dependent Regulation of HOXB7. Zhao X; Dong W; Luo G; Xie J; Liu J; Yu F Mol Cell Biol; 2021 May; 41(6):e0063120. PubMed ID: 33782039 [TBL] [Abstract][Full Text] [Related]
16. Hsa_circRNA_102229 facilitates the progression of triple-negative breast cancer via regulating the miR-152-3p/PFTK1 pathway. Du C; Zhang J; Zhang L; Zhang Y; Wang Y; Li J J Gene Med; 2021 Sep; 23(9):e3365. PubMed ID: 34031947 [TBL] [Abstract][Full Text] [Related]
17. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis. Jin J; Liu H; Jin M; Li W; Xu H; Wei F Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866 [TBL] [Abstract][Full Text] [Related]
18. Circular RNA hsa_circ_0054537 sponges miR-130a-3p to promote the progression of renal cell carcinoma through regulating cMet pathway. Li R; Luo S; Zhang D Gene; 2020 Sep; 754():144811. PubMed ID: 32464246 [TBL] [Abstract][Full Text] [Related]
19. Hsa_circ_0069094 positively regulates the expression of oncogenic ZNF217 by competitively targeting miR-758-3p to promote the development of breast cancer. Ou H; Li J; Lv Q; Feng D Reprod Biol; 2022 Dec; 22(4):100708. PubMed ID: 36356557 [TBL] [Abstract][Full Text] [Related]
20. RNA-binding protein IGF2BP2 enhances circ_0000745 abundancy and promotes aggressiveness and stemness of ovarian cancer cells via the microRNA-3187-3p/ERBB4/PI3K/AKT axis. Wang S; Li Z; Zhu G; Hong L; Hu C; Wang K; Cui K; Hao C J Ovarian Res; 2021 Nov; 14(1):154. PubMed ID: 34774079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]